![CytoDyn Logo](/news-release/logo/298321/0/298321.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A35&size=2)
CytoDyn Announces Investor Call to Provide Update on Clinical Development Strategy
May 15, 2014 08:00 ET
|
CytoDyn
VANCOUVER, Wash., May 15, 2014 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency...
![CytoDyn Logo](/news-release/logo/298321/0/298321.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A35&size=2)
CytoDyn Inc. Announces First HIV Patient Dosing With PRO 140 in Phase 2b Clinical Trial for Treatment Substitution Protocol
May 14, 2014 08:00 ET
|
CytoDyn
VANCOUVER, Wash., May 14, 2014 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB:CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency...
![CytoDyn Logo](/news-release/logo/298321/0/298321.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A35&size=2)
CytoDyn to Develop Nonsynthetic Cancer Drug
March 28, 2006 09:00 ET
|
CytoDyn
SANTE FE, N.M., March 28, 2006 (PRIMEZONE) -- CytoDyn, Inc. (OTCBB:CYDY), best known for Cytolin(r), a targeted immune therapy for treating HIV/AIDS, has announced plans to develop a nonsynthetic...
![CytoDyn Logo](/news-release/logo/298321/0/298321.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A35&size=2)
CytoDyn Applies for Cancer Drug Trademark: Formaxycin
March 27, 2006 09:00 ET
|
CytoDyn
SANTA FE, N.M., March 27, 2006 (PRIMEZONE) -- CytoDyn, Inc. (OTCBB:CYDY) has applied for the trademark Formaxycin(tm) (fer-MAX-uh-sin) to brand its new cancer drug. Like several approved cancer drugs,...
![CytoDyn Logo](/news-release/logo/298321/0/298321.jpg?lastModified=12%2F09%2F2016%2022%3A38%3A35&size=2)
CytoDyn CEO Explains Company's Strategy to Prevent Drug-Resistant Germs
March 20, 2006 09:00 ET
|
CytoDyn
ALBUQUERQUE, N.M., March 20, 2006 (PRIMEZONE) -- A recent meeting of the New Mexico Biotechnology & Biomedical Association featured a talk by Allen D. Allen, CEO of CytoDyn, Inc. (OTCBB:CYDY)....